Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Jean-Baptiste Bossard"'
Autor:
Adrien Daniel, David Ghez, Camille Ravaiau, Doriane Cavalieri, Olivier Tournilhac, Charles Herbaux, Mélanie Roriz, Mathieu Wemeau, Stéphanie Guillet, Jean Baptiste Bossard, Demarquette Hélène, Eleonore Kaphan, Regny Caroline, Lachenal Florence, Adeline Pierache, Marc Michel, Bertrand Godeau, Louis Terriou
Publikováno v:
European Journal of Haematology. 109:719-727
Autoimmune conditions in B-cell lymphomas are frequent. Steroids are standard of care, but many patients require other immunosuppressive agents. Ibrutinib is a Bruton Tyrosine Kinase inhibitor that is approved for B-cell indolent lymphoma treatment.
Autor:
Nathalie Cambier, Guillaume Chanteau, Guillaume Escure, Remi Tilmont, Mathieu Wemeau, Jean Baptiste Bossard, Loïc Renaud, Julia Hieulle, Sarah Barbieux, Franck Morschhauser, Eileen M Boyle, Louis Terriou, Benjamin Carpentier
Publikováno v:
European Journal of Haematology
European Journal of Haematology, 2021, European Journal of Haematology, 107 (3), pp.370-373. ⟨10.1111/ejh.13667⟩
European Journal of Haematology, 2021, European Journal of Haematology, 107 (3), pp.370-373. ⟨10.1111/ejh.13667⟩
Despite recent therapeutic advances the outcome of elderly or frail patients with Recurrent/Refractory (R/R) Primary (PCNSL) and Secondary CNS Lymphoma (SCNSL) is particularly dire. We retrospectively analyzed 22 immunocompetent adults with R/R PCNSL
Publikováno v:
Annales de biologie clinique.
Autor:
Jean-Baptiste Bossard, Société Francophone de Greffe de Moelle et de Thérapie Cellulaire, Mohamad Mohty, Florence Beckerich, Marie-Thérèse Rubio, Patrice Chevallier, Jérôme Cornillon, Fiorenza Barraco, Federico Garnier, Marie Robin, Alain Duhamel, Gandhi Damaj, Corentin Orvain, Jean-Baptiste Beuscart, Ibrahim Yakoub-Agha, Mathieu Meunier, Thomas Cluzeau, Amandine Charbonnier, Patrice Ceballos, Didier Blaise, Carmen Botella-Garcia, Jean-Jacques Kiladjian, Jacques-Olivier Bay, Tony Marchand
Publikováno v:
American Journal of Hematology
American Journal of Hematology, Wiley, 2021, 96 (1), pp.80-88. ⟨10.1002/ajh.26034⟩
American Journal of Hematology, Wiley, 2021, 96 (1), pp.80-88. ⟨10.1002/ajh.26034⟩
The value of pretransplant splenectomy in patients with myelofibrosis (MF) is subject to debate, since the procedure may preclude subsequent allogeneic hematopoietic cell transplantation (allo-HCT). To determine the impact of pretransplant splenectom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49113b46f2ebd0e35ede9bc08654603b
https://hal.uca.fr/hal-03089653
https://hal.uca.fr/hal-03089653
Autor:
Franck Morschhauser, Jean-Baptiste Bossard, Julia Hieulle, Nathalie Cambier, Benjamin Carpentier, Louis Terriou, Mathieu Wemeau, Eileen M Boyle, Sarah Barbieux, Loïc Renaud, Guillaume Chanteau
Publikováno v:
Blood. 136:23-24
I ntroduction Despite recent therapeutic progress in this field, the prognosis of elderly patients with Primary (PCNSL) and Secondary Central Nervous System Lymphoma (SCNSL) remains poor, with a median OS of less than two years in most prospective st
Autor:
Hélène Demarquette, Eileen M Boyle, Leduc I, Salomon Manier, Pauline Lionne-Huyghe, Laurent Pascal, Charles Herbaux, Van de Wyngaert Z, S. Barbieux, Srour M, Willaume A, Jean-Baptiste Bossard, Vasseur M, P. Chauvet, Claire Bories, Thierry Facon, Louis Terriou, Gibier Jb, Morgane Nudel, Benjamin Carpentier
Publikováno v:
British Journal of Haematology. 188
Autor:
Loïc Renaud, Jean-Baptiste Bossard, Zoé Van de Wyngaert, Sarah Barbieux, Alexandre Willaume, Guillaume Escure, Claire Bories, Bruno Quesnel, Serge Alfandari, Marie Titecat, Morgane Nudel, Céline Berthon, Sarah Bonnet, Benjamin Carpentier, Houria Debarri, Paul Chauvet, Ines Arib, Nicolas Branche, Arthur Simonnet, Kevin James Wattebled, Charline Legrand
Publikováno v:
International Journal of Antimicrobial Agents
International Journal of Antimicrobial Agents, 2019, 53, pp.781-788. ⟨10.1016/j.ijantimicag.2019.02.020⟩
International Journal of Antimicrobial Agents, 2019, 53, pp.781-788. ⟨10.1016/j.ijantimicag.2019.02.020⟩
Objectives Antibiotics for febrile neutropenia (FN) in acute myeloid leukaemia (AML) patients undergoing intensive chemotherapy are usually maintained until neutropenia resolution, because of the risk of uncontrolled sepsis in this vulnerable populat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5cc10918ec26fb206ab34342a2c85606
https://hal.archives-ouvertes.fr/hal-03484940/file/S0924857919300500.pdf
https://hal.archives-ouvertes.fr/hal-03484940/file/S0924857919300500.pdf
Autor:
Mathieu Wemeau, Kamel Laribi, Romain Dubois, Brigitte Dreyfus, Stéphanie Poulain, Cécile Tomowiak, Jehan Dupuis, Frédéric Wallyn, Hélène Demarquette, Héloïse Dapvril, Florence Cymbalista, Charles Herbaux, Jacques-Olivier Bay, Jean-Baptiste Bossard, Franck Morschhauser, Morgane Nudel, Lidwine Wemeau, Stéphane Leprêtre, Fanny Baran-Marszak
Publikováno v:
British Journal of Haematology
British Journal of Haematology, 2019, 186 (5), pp.e126-e130. ⟨10.1111/bjh.15966⟩
British Journal of Haematology, Wiley, 2019, 186 (5), pp.e126-e130. ⟨10.1111/bjh.15966⟩
British Journal of Haematology, 2019, 186 (5), pp.e126-e130. ⟨10.1111/bjh.15966⟩
British Journal of Haematology, Wiley, 2019, 186 (5), pp.e126-e130. ⟨10.1111/bjh.15966⟩
International audience; No abstract available
Publikováno v:
Clinical drug investigation. 36(9)
Pregabalin abuse and dependence has been increasingly described; however, it is not described in France. Our study aimed to investigate the abuse and dependence potential of pregabalin by a disproportionality analysis, in the French Pharmacovigilance
Autor:
Jean-Baptiste Gibier, Eileen M Boyle, Jean-Baptiste Bossard, Claire Bories, Arthur Simonnet, Hélène Demarquette, Zoé Van de Wyngaert, Salomon Manier, Benjamin Carpentier, Sarah Barbieux, Thierry Facon, Paul Chauvet, Micha Srour, Julia Hieulle, Laurent Pascal, Charles Herbaux, Isabelle Leduc, Pauline Lionne, Morgane Nudel, Alexandre Willaume, Michèle Vasseur
Publikováno v:
Blood. 132:5660-5660
Introduction: Systemic Light-chain amyloidosis (AL) is a clonal plasma-cell disorder, and has therefore benefited from the numerous therapeutic advances in multiple myeloma (MM). Nonetheless, outcome of refractory AL patients remains dire, especially